Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AUPH Aurinia Pharmaceuticals Inc

已收盘 11-21 16:00:00 EST

8.77

+0.53

+6.43%

盘后8.77

+0.000.00%

19:59 EST

最高8.83	最低8.30	成交量241.74万
今开8.31	昨收8.24	日振幅6.43%
总市值12.56亿	流通市值11.55亿	总股本1.43亿
成交额2,078万	换手率1.84%	流通股本1.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AUPH","market":"US","secType":"STK","nameCN":"Aurinia Pharmaceuticals Inc","latestPrice":8.77,"timestamp":1732222800000,"preClose":8.24,"halted":0,"volume":2417356,"hourTrading":{"tag":"盘后","latestPrice":8.77,"preClose":8.77,"latestTime":"19:59 EST","volume":10995,"amount":96432.5352,"timestamp":1732237198745},"delay":0,"floatShares":131668028,"shares":143179269,"eps":-0.157225,"marketStatus":"已收盘","marketStatusCode":5,"change":0.53,"latestTime":"11-21 16:00:00 EST","open":8.311,"high":8.83,"low":8.3,"amount":20776068.87963,"amplitude":0.06432,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.157225,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":951454800000,"adjPreClose":8.24,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.34,"preClose":8.24,"latestTime":"09:29 EST","volume":2037,"amount":16981.749938999998,"timestamp":1732199399999},"postHourTrading":{"tag":"盘后","latestPrice":8.77,"preClose":8.77,"latestTime":"19:59 EST","volume":10995,"amount":96432.5352,"timestamp":1732237198745},"volumeRatio":1.836534,"impliedVol":0.5215,"impliedVolPercentile":0.2619},"requestUrl":"/m/hq/s/AUPH","defaultTab":"news","newsList":[{"id":"2484924548","title":"Aurinia Pharmaceuticals Inc2024财年第三财季实现净利润14.35百万美元，同比增加206.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484924548?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:02","pubTimestamp":1731772946,"startTime":"0","endTime":"0","summary":"11月17日，Aurinia Pharmaceuticals Inc公布财报，公告显示公司2024财年第三财季净利润为14.35百万美元，同比增加206.69%；其中营业收入为67.77百万美元，同比增加24.30%，每股基本收益为0.10美元。机构评级：截至2024年11月17日，当前有7家机构对Aurinia Pharmaceuticals Inc目标价做出预测，其中目标均价为10.84美元，其中最低目标价为8.00美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000320a23e064a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000320a23e064a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUPH"],"gpt_icon":0},{"id":"1154738439","title":"异动解读 | Aurinia Pharmaceuticals大幅裁员重组 盘中股价大涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154738439","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154738439?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:49","pubTimestamp":1730990947,"startTime":"0","endTime":"0","summary":"Aurinia Pharmaceuticals Inc今日盘中大涨7.06%,引发了市场的广泛关注。公司宣布将进行大规模重组,包括裁员约28%的全职员工,优化临床开发项目组合,以及外包部分非核心职能等措施。重组过程中,Aurinia将继续专注于其主打产品Lupkynis的市场推广工作,并寻求与潜在战略合作伙伴的合作,以加速实现公司的商业目标。投资者对这一重组计划反映了积极态度,公司股价盘中大涨反映了市场对其未来发展前景的充满信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AUPH"],"gpt_icon":0},{"id":"2481186028","title":"Aurinia Pharmaceuticals Inc盘中异动 早盘股价大涨7.05%报8.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481186028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481186028?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:31","pubTimestamp":1730989875,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时31分，Aurinia Pharmaceuticals Inc股票出现波动，股价大幅拉升7.05%。截至发稿，该股报8.05美元/股，成交量10.3461万股，换手率0.07%，振幅0.00%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Ensysce Biosciences, Inc.、Mustang Bio, Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为76.92%、54.48%、47.54%，振幅较大的相关个股有Tuhura Biosciences, Inc.、Immunic, Inc.、Fennec Pharmaceuticals Inc.，振幅分别为8.54%、5.93%、4.85%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223115a220ec2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223115a220ec2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AUPH"],"gpt_icon":0},{"id":"1163681819","title":"异动解读 | Aurinia Pharmaceuticals公司宣布重组计划 盘前股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1163681819","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163681819?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:26","pubTimestamp":1730989593,"startTime":"0","endTime":"0","summary":"Aurinia Pharmaceuticals Inc (股票代码:AUPH)今日盘前大涨6.65%,引发市场广泛关注。公司宣布将进行重组,包括裁员和优化运营,旨在降低运营成本、提高效率。\n\nAurinia表示,在当前经济环境下,为了确保公司长期可持续发展,必须采取一些艰难但关键的措施。此次重组计划预计可节省大约1.25亿美元的年度运营支出。\n\n重组的具体内容包括裁员约28%的全职员工,优化临床开发项目组合,外包部分非核心职能等。Aurinia还将继续专注于其主打产品Lupkynis的市场推广,并寻求战略性合作伙伴关系,以加速实现商业目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AUPH"],"gpt_icon":0},{"id":"2467770983","title":"BUZZ-Tang Capital 报告持有 Aurinia Pharmaceuticals 5.1% 股份后，该公司股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467770983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467770983?lang=zh_cn&edition=full","pubTime":"2024-09-13 23:52","pubTimestamp":1726242759,"startTime":"0","endTime":"0","summary":"    9月13日 - ** 在美国上市的制药公司Aurinia Pharmaceuticals   股价上涨6.6%，报7.01美元** 唐人资本管理公司报告称，截至9月6日，该公司持有AUPH公司5.1%的股份。** AUPH 称，Greenleaf 已有条件辞去董事职务，因为他在 2024 年股东大会上获得的支持率低于多数。** 公司董事会称已考虑了所有相关因素，并确定存在特殊情况，需要拒绝Greenleaf的有条件辞职。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AUPH","BK4139","AGMH","BK4112"],"gpt_icon":0},{"id":"2458341988","title":"Aurinia Pharmaceuticals Inc2024财年第二财季实现净利润722000.00美元，同比增加106.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458341988","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458341988?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:22","pubTimestamp":1723134174,"startTime":"0","endTime":"0","summary":"8月9日，Aurinia Pharmaceuticals Inc公布财报，公告显示公司2024财年第二财季净利润为722000.00美元，同比增加106.28%；其中营业收入为57.19百万美元，同比增加37.84%，每股基本收益为0.01美元。机构评级：截至2024年8月9日，当前有7家机构对Aurinia Pharmaceuticals Inc目标价做出预测，其中目标均价为9.57美元，其中最低目标价为6.00美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090022579f1afcfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090022579f1afcfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUPH"],"gpt_icon":0},{"id":"2457005096","title":"Aurinia Pharmaceuticals Inc盘中异动 急速拉升5.03%报5.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457005096","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457005096?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:53","pubTimestamp":1722974004,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日03时53分，Aurinia Pharmaceuticals Inc股票出现异动，股价大幅上涨5.03%。截至发稿，该股报5.64美元/股，成交量134.223万股，换手率0.94%，振幅8.29%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.29%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807035324aefd8a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807035324aefd8a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUPH","BK4139"],"gpt_icon":0},{"id":"2456424744","title":"Aurinia Pharmaceuticals Inc: Leerink Partners将目标价从15美元降至11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456424744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456424744?lang=zh_cn&edition=full","pubTime":"2024-08-02 15:24","pubTimestamp":1722583463,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AUPH","BK4139"],"gpt_icon":0},{"id":"2455156537","title":"Aurinia Pharmaceuticals Inc盘中异动 早盘股价大涨5.16%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455156537","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455156537?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:08","pubTimestamp":1722438481,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时08分，Aurinia Pharmaceuticals Inc股票出现波动，股价快速拉升5.16%。截至发稿，该股报5.91美元/股，成交量60.0126万股，换手率0.42%，振幅4.98%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.17%。其相关个股中，Renovaro Inc.、Zevra Therapeutics, Inc.、Applied Therapeutics, Inc.涨幅较大，Bionomics Ltd Ads Each Rep 180 Ord Shs、Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为135.92%、124.70%、122.54%，振幅较大的相关个股有Renovaro Inc.、Alpha Tau Medical Ltd C/Wts 、Salarius Pharmaceuticals, Inc.，振幅分别为79.10%、44.12%、40.61%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230801941fca15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230801941fca15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AUPH"],"gpt_icon":0},{"id":"2453719871","title":"Aurinia Pharmaceuticals Inc盘中异动 下午盘股价大跌5.13%报5.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453719871","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453719871?lang=zh_cn&edition=full","pubTime":"2024-07-23 02:04","pubTimestamp":1721671464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日02时04分，Aurinia Pharmaceuticals Inc股票出现波动，股价大幅下跌5.13%。截至发稿，该股报5.28美元/股，成交量79.3954万股，换手率0.56%，振幅6.65%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为122.46%、113.38%、73.96%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723020425af937631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723020425af937631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AUPH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.auriniapharma.com","stockEarnings":[{"period":"1week","weight":-0.0048},{"period":"1month","weight":0.1492},{"period":"3month","weight":0.2391},{"period":"6month","weight":0.5816},{"period":"1year","weight":-0.0572},{"period":"ytd","weight":-0.0834}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aurinia Pharmaceuticals Inc.是根据《商业公司法》组建的（加拿大阿尔伯塔省）。Aurinia制药是一家完全整合的生物制药公司，专注于提供治疗目标患者群体的疗法，这些患者群体受到自身免疫、肾脏和罕见病的影响，医疗需求未得到满足。2021年1月，Aurinia制药推出了首个获得FDA批准的口服药物LUPKYNIS（voclosporin），用于治疗活动性LN成人患者。LUPKYNIS是一种口服CNI免疫抑制剂，当与霉酚酸酯（MMF）（尽管MMF目前尚未被批准）和类固醇联合使用时，已被证明可以改善LN的近期和长期结果。通过抑制钙调神经磷酸酶，LUPKYNIS降低细胞因子活化，阻断白细胞介素IL-2表达和T细胞介导的免疫反应。LUPKYNIS还可能稳定足细胞，从而防止蛋白尿。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106403},{"month":2,"riseRate":0.5,"avgChangeRate":0.009372},{"month":3,"riseRate":0.4,"avgChangeRate":0.102117},{"month":4,"riseRate":0.6,"avgChangeRate":-0.012088},{"month":5,"riseRate":0.6,"avgChangeRate":-0.004093},{"month":6,"riseRate":0.4,"avgChangeRate":-0.030211},{"month":7,"riseRate":0.6,"avgChangeRate":0.036556},{"month":8,"riseRate":0.5,"avgChangeRate":-0.045687},{"month":9,"riseRate":0.5,"avgChangeRate":0.078058},{"month":10,"riseRate":0.545455,"avgChangeRate":0.035973},{"month":11,"riseRate":0.545455,"avgChangeRate":0.011534},{"month":12,"riseRate":0.4,"avgChangeRate":0.111111}],"exchange":"NASDAQ","name":"Aurinia Pharmaceuticals Inc","nameEN":"Aurinia Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aurinia Pharmaceuticals Inc(AUPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aurinia Pharmaceuticals Inc,AUPH,Aurinia Pharmaceuticals Inc股票,Aurinia Pharmaceuticals Inc股票老虎,Aurinia Pharmaceuticals Inc股票老虎国际,Aurinia Pharmaceuticals Inc行情,Aurinia Pharmaceuticals Inc股票行情,Aurinia Pharmaceuticals Inc股价,Aurinia Pharmaceuticals Inc股市,Aurinia Pharmaceuticals Inc股票价格,Aurinia Pharmaceuticals Inc股票交易,Aurinia Pharmaceuticals Inc股票购买,Aurinia Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aurinia Pharmaceuticals Inc(AUPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}